Antibody Drug Regeneron Enters Clinical Trials At Um

Antibody Drug Regeneron Enters Clinical Trials At UM

Regeneron's science chief on starting clinical trials for Covid-19 antibody drug

CNBC Television

Regeneron Covid-19 'antibody cocktail' drug enters late-stage trials

CNBC Television

Regeneron reports antibody drug lowers risk of medical visits by 57%

CNBC Television

Regeneron aims for COVID-19 drug trials by early summer

CNBC Television

Regeneron's antibody drug reduces risk of death in some Covid patients

CNBC Television

Trial: NY-based Regeneron's antibody drug reduces COVID-19 hospitalization risk, death by 70%

UW Health testing same Regeneron Pharmaceutical clinical trial

Channel 3000 / News 3 Now

Coronavirus treatment: Roche, Regeneron team up to make COVID-19 antibody drug

Regeneron Clinical Trials In Colorado Leave Some Optimistic

First Regeneron trial began at Holy Name Medical Center

NJ Spotlight News

Holy Name Offers Promising New Regeneron Clinical Trial for Covid-19

Regeneron's Antibody Drug Helps Prevent COVID-19 For Up To 8 Months, Company Trial Results Show

Regeneron antibody cocktail used in clinical trials to fight COVID-19 at UCHealth

Dr. Nachman weighs in on the new Regeneron study

FDA Approves Regeneron’s Covid-19 Antibody Treatment | NBC Nightly News

Spectrum Hosting Regeneron Clinical Trials

Doctors share excitement about Regeneron antibody cocktail treatment study

WLWT

Regeneron's Antibody Drug Helps Prevent COVID-19 For Up To 8 Months, Company Trial Results Show

Regeneron trial in WNY